On September 25, 2015, an objection to the determination of the amount of a cure claim was filed in the bankruptcy case of Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) and its affiliates.
The filing was assigned docket number 179 and is described on the court’s official docket as follows:
Objection to Cure Costs and Reservation of Rights (related document(s)) Filed by Joi C. True, Esq. (NAB)
Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on August 9, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-11663. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Pachulski Stang Ziehl & Jones LLP is acting as lead bankruptcy counsel to Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) in the bankruptcy case.